European Journal of Internal Medicine
Volume 19, Issue 4 , Pages 227-235 , June 2008

Acute exacerbation of idiopathic pulmonary fibrosis: A systematic review

Received 15 November 2006 ,Revised 20 April 2007 ,Accepted 23 April 2007.

References 

  1. American Thoracic Society . Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161:646–664
  2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias . This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277–304
  3. Noble PW. Idiopathic pulmonary fibrosis: natural history and prognosis. Clin Chest Med. 2006;27:S11–S16v.
  4. Hamman L, Rich AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc. 1935;51:154–163
  5. Hamman L, Rich AR. Acute diffuse interstitial fibrosis of the lungs. Bull Hopkins Hosp. 1944;74:177–212
  6. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157:1301–1315
  7. Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol. 1986;10:256–267
  8. Vourlekis JS, Brown KK, Schwarz MI. Acute interstitial pneumonitis: current understanding regarding diagnosis, pathogenesis, and natural history. Semin Respir Crit Care Med. 2001;22:399–408
  9. Olson J, Colby TV, Elliott CG. Hamman–Rich syndrome revisited. Mayo Clin Proc. 1990;65:1538–1548
  10. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125–133
  11. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142:963–967
  12. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006;27:143–150
  13. Okamoto T, Ichiyasu H, Ichikado K, Muranaka H, Sato K, Okamoto S, et al. Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis. Nihon Kokyuki Gakkai Zasshi. 2006;44:359–367
  14. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:1040–1047
  15. Hiwatari N, Shimura S, Takishima T, Shirato K. Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. Tohoku J Exp Med. 1994;174:379–386
  16. Kondoh Y, Taniguchi H, Kitaichi M, Yokoi T, Johkoh T, Oishi T, et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med. 2006;100:1753–1759
  17. Honore I, Nunes H, Groussard O, Kambouchner M, Chambellan A, Aubier M, et al. Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis. Am J Respir Crit Care Med. 2003;167:953–957
  18. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 1999;341:1264–1269
  19. Loutit JS, Safrin S, Suzuki S, Bradford WZ. Serious adverse events (SAEs) of the respiratory tract in patients with idiopathic pulmonary fibrosis (IPF) treated with interferon gamma-1b (IFN-gamma 1b) in three trials. Eur Respir J. 2005;26:336s
  20. Crowley SP, Kelly P, Egan JJ. Acute exacerbations in idiopathic pulmonary fibrosis. Ann Intern Med. 2006;144:218;author reply-9
  21. Jindal SK, Agarwal R. Autoimmunity and interstitial lung disease. Curr Opin Pulm Med. 2005;11:438–446
  22. Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia. The whole story or the last chapter of a long novel. Chest. 2005;128:526S–532S
  23. Noble PW, Homer RJ. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin Chest Med. 2004;25:749–758vii
  24. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–525
  25. Rice AJ, Wells AU, Bouros D, du Bois RM, Hansell DM, Polychronopoulos V, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol. 2003;119:709–714
  26. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest. 1993;103:1808–1812
  27. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol. 1997;168:79–83
  28. Gong MN, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea. N Engl J Med. 2002;347:2149–2157
  29. Kim DS, Collard HR, King TE. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006;3:285–292
  30. Chuang M-L, Lin I-F, Tsai Y-H, Vintch JRE, Pang L-C. The utility of open lung biopsy in patients with diffuse pulmonary infiltrates as related to respiratory distress, its impact on decision making by urgent intervention, and the diagnostic accuracy based on the biopsy location. J Intensive Care Med. 2003;18:21–28
  31. Wagner JD, Stahler C, Knox S, Brinton M, Knecht B. Clinical utility of open lung biopsy for undiagnosed pulmonary infiltrates. Am J Surg. 1992;164:104–107discussion 8
  32. Patel SR, Karmpaliotis D, Ayas NT, Mark EJ, Wain J, Thompson BT, et al. The role of open-lung biopsy in ARDS. Chest. 2004;125:197–202
  33. Ambrosini V, Cancellieri A, Chilosi M, Zompatori M, Trisolini R, Saragoni L, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J. 2003;22:821–826
  34. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest. 2005;128:3310–3315
  35. Beskow CO, Drachenberg CB, Bourquin PM, Britt EJ, Simsir A, Gunev I, et al. Diffuse alveolar damage. Morphologic features in bronchoalveolar lavage fluid. Acta Cytol. 2000;44:640–646
  36. Antonelli M, Conti G, Rocco M, Arcangeli A, Cavaliere F, Proietti R, et al. Noninvasive positive–pressure ventilation vs conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest. 2002;121:1149–1154
  37. Inase N, Sawada M, Ohtani Y, Miyake S, Isogai S, Sakashita H, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med. 2003;42:565–570
  38. Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. Intern Med. 2005;44:1144–1150
  39. Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest. 2005;128:1475–1482
  40. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Oishi T, Kato T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005;25:528–533
  41. Nishiyama O, Shimizu M, Ito Y, Kume H, Suzuki R, Yokoi T, et al. Effect of prolonged low-dose methylprednisolone therapy in acute exacerbation of idiopathic pulmonary fibrosis. Respir Care. 2001;46:698–701
  42. Stern JB, Mal H, Groussard O, Brugiere O, Marceau A, Jebrak G, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest. 2001;120:213–219
  43. Lok SS, Smith E, Doran HM, Sawyer R, Yonan N, Egan JJ. Idiopathic pulmonary fibrosis and cyclosporine: a lesson from single-lung transplantation. Chest. 1998;114:1478–1481
  44. Robinson DS, Geddes DM, Hansell DM, Shee CD, Corbishley C, Murday A, et al. Partial resolution of acute interstitial pneumonia in native lung after single lung transplantation. Thorax. 1996;51:1158–1159discussion 64-9

PII: S0953-6205(07)00350-0

doi: 10.1016/j.ejim.2007.04.024

European Journal of Internal Medicine
Volume 19, Issue 4 , Pages 227-235 , June 2008

Article Tools

* Image Usage & Resolution